Ards - Open Access .click

Results 21 to 30 of about 158,510 (246)

Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey

Critical Care, 2020
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) appeared just over 7 months ago in Wuhan, China.
S. Tzotzos +3 more
semanticscholar +1 more source

Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment

Frontiers in Immunology, 2022
Acute lung injury/acute respiratory distress syndrome (ALI/ARDS) is a common condition with high mortality. ALI/ARDS is caused by multiple etiologies, and the main clinical manifestations are progressive dyspnea and intractable hypoxemia.
Chang Liu, K. Xiao, L. Xie
semanticscholar +1 more source

Obesity and ARDS [PDF]

Chest, 2012
Obesity prevalence continues to increase globally, with figures exceeding 30% of some populations. Patients who are obese experience alterations in baseline pulmonary mechanics, including airflow obstruction, decreased lung volumes, and impaired gas exchange. These physiologic changes have implications in many diseases, including ARDS.
Mary B. Rice, Kathryn A. Hibbert, Atul Malhotra +2 more
openaire +3 more sources

Clinical features, ventilatory management, and outcome of ARDS caused by COVID-19 are similar to other causes of ARDS

Intensive Care Medicine, 2020
The main characteristics of mechanically ventilated ARDS patients affected with COVID-19, and the adherence to lung-protective ventilation strategies are not well known.
Carlos Ferrando +442 more
semanticscholar +1 more source

Permissive hypercapnia in ARDS [PDF]

Intensive Care Medicine, 1998
Jordi Mancebo
openalex +4 more sources

Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study

Critical Care, 2020
Background Previous studies suggest that prone positioning (PP) can increase PaO 2 /FiO 2 and reduce mortality in moderate to severe acute respiratory distress syndrome (ARDS).
L. Ding, Li Wang, Wanhong Ma, Hangyong He +3 more
semanticscholar +1 more source

Myorelaxants in ARDS patients [PDF]

Intensive Care Medicine, 2020
Neuromuscular blocking agents (NMBAs) inhibit patient-initiated active breath and the risk of high tidal volumes and consequent high transpulmonary pressure swings, and minimize patient/ ventilator asynchrony in acute respiratory distress syndrome (ARDS).
Hraiech, Sami +9 more
openaire +7 more sources

Prone position in ARDS patients: why, when, how and for whom

Intensive Care Medicine, 2020
In ARDS patients, the change from supine to prone position generates a more even distribution of the gas–tissue ratios along the dependent–nondependent axis and a more homogeneous distribution of lung stress and strain.
C. Guérin +10 more
semanticscholar +1 more source

Impact of sweep gas flow on extracorporeal CO2 removal (ECCO2R)

Intensive Care Medicine Experimental, 2019
Background Veno-venous extracorporeal carbon dioxide (CO2) removal (vv-ECCO2R) is increasingly being used in the setting of acute respiratory failure.
Stephan Strassmann +7 more
doaj +1 more source

Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS

Frontiers in Immunology, 2022
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is a critical clinical syndrome with high morbidity and mortality that poses a major challenge in critical care medicine.
Chang Liu, K. Xiao, L. Xie
semanticscholar +1 more source

medicine
lung
internal medicine

intensive care medicine
covid-19
anesthesia

mechanical ventilation
pathology
respiratory distress